| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 2813 | 2018 |
| Multiparametric MRI for prostate cancer diagnosis: current status and future directions A Stabile, F Giganti, AB Rosenkrantz, SS Taneja, G Villeirs, IS Gill, C Allen, ... Nature Reviews Urology 17 (1), 41-61, 2020 | 307 | 2020 |
| A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance … G Gandaglia, G Ploussard, M Valerio, A Mattei, C Fiori, N Fossati, ... European urology 75 (3), 506-514, 2019 | 250 | 2019 |
| Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis V Kasivisvanathan, A Stabile, JB Neves, F Giganti, M Valerio, ... European urology 76 (3), 284-303, 2019 | 204 | 2019 |
| Medium‐term oncological outcomes in a large cohort of men treated with either focal or hemi‐ablation using high‐intensity focused ultrasonography for primary localized prostate … A Stabile, C Orczyk, F Hosking‐Jervis, F Giganti, M Arya, RG Hindley, ... BJU international 124 (3), 431-440, 2019 | 122 | 2019 |
| Identifying the optimal candidate for salvage lymph node dissection for nodal recurrence of prostate cancer: results from a large, multi-institutional analysis N Fossati, N Suardi, G Gandaglia, CA Bravi, M Soligo, RJ Karnes, ... European urology 75 (1), 176-183, 2019 | 120 | 2019 |
| Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis E Mazzone, A Stabile, F Pellegrino, G Basile, D Cignoli, GO Cirulli, ... European urology oncology 4 (5), 697-713, 2021 | 117 | 2021 |
| Radical prostatectomy in men with oligometastatic prostate cancer: results of a single-institution series with long-term follow-up G Gandaglia, N Fossati, A Stabile, M Bandini, P Rigatti, F Montorsi, ... European urology 72 (2), 289-292, 2017 | 114 | 2017 |
| The key combined value of multiparametric magnetic resonance imaging, and magnetic resonance imaging–targeted and concomitant systematic biopsies for the prediction of adverse … G Gandaglia, G Ploussard, M Valerio, A Mattei, C Fiori, M Roumiguié, ... European urology 77 (6), 733-741, 2020 | 101 | 2020 |
| Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review A Stabile, F Giganti, V Kasivisvanathan, G Giannarini, CM Moore, ... European urology oncology 3 (2), 145-167, 2020 | 98 | 2020 |
| The impact of experience on the risk of surgical margins and biochemical recurrence after robot-assisted radical prostatectomy: a learning curve study CA Bravi, A Tin, E Vertosick, E Mazzone, A Martini, P Dell'Oglio, A Stabile, ... The Journal of urology 202 (1), 108-113, 2019 | 88 | 2019 |
| Contemporary incidence and cancer control outcomes of primary neuroendocrine prostate cancer: a SEER database analysis E Zaffuto, R Pompe, M Zanaty, HD Bondarenko, SR Leyh-Bannurah, ... Clinical genitourinary cancer 15 (5), e793-e800, 2017 | 78 | 2017 |
| External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection G Gandaglia, A Martini, G Ploussard, N Fossati, A Stabile, P De Visschere, ... European urology 78 (2), 138-142, 2020 | 76 | 2020 |
| Not all multiparametric magnetic resonance imaging–targeted biopsies are equal: the impact of the type of approach and operator expertise on the detection of clinically … A Stabile, P Dell’Oglio, G Gandaglia, N Fossati, G Brembilla, G Cristel, ... European Urology Oncology 1 (2), 120-128, 2018 | 76 | 2018 |
| Can negative prostate-specific membrane antigen positron emission tomography/computed tomography avoid the need for pelvic lymph node dissection in newly diagnosed prostate … A Stabile, A Pellegrino, E Mazzone, D Cannoletta, M de Angelis, ... European Urology Oncology 5 (1), 1-17, 2022 | 69 | 2022 |
| Focal therapy for localized prostate cancer with either high intensity focused ultrasound or cryoablation: a single institution experience RR Tourinho-Barbosa, R Sanchez-Salas, OR Claros, S Collura-Merlier, ... The Journal of urology 203 (2), 320-330, 2020 | 69 | 2020 |
| Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study using the … UG Falagario, I Jambor, A Lantz, O Ettala, A Stabile, P Taimen, HJ Aronen, ... European urology oncology 4 (6), 971-979, 2021 | 68 | 2021 |
| Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 G Brembilla, P Dell’Oglio, A Stabile, A Damascelli, L Brunetti, S Ravelli, ... European radiology 30, 3383-3392, 2020 | 66 | 2020 |
| Association between Prostate Imaging Reporting and Data System (PI-RADS) score for the index lesion and multifocal, clinically significant prostate cancer A Stabile, P Dell’Oglio, F De Cobelli, A Esposito, G Gandaglia, N Fossati, ... European urology oncology 1 (1), 29-36, 2018 | 59 | 2018 |
| The evolution of MRI of the prostate: the past, the present, and the future F Giganti, AB Rosenkrantz, G Villeirs, V Panebianco, A Stabile, ... American Journal of Roentgenology 213 (2), 384-396, 2019 | 57 | 2019 |
